Using this approach, we defined the anti-TFEB binding DNA sequence in PCa cells, and qRT-PCR revealed that TFEB had binding sites located within the ABCA2 promoter region, one of which showed a higher binding capacity (P1>P2). The gene discussed is ABCA2; the disease is posterior cortical atrophy.